US Patent 10093731 Anti-IL31 antibodies for veterinary use
Patent 10093731 was granted and assigned to Kindred Biosciences, Inc. on October, 2018 by the United States Patent and Trademark Office.
All edits
Edits on 8 Dec, 2023
Golden AI
Edits made to:
Article (+237 characters)
Article
Patent abstract
Provided are various embodiments relating to anti-IL31 antibodies binding to canine IL31. Such antibodies can be used in methods to treat IL31-induced conditions in companion animals, such as canines, felines, and equines.
Edits on 1 Oct, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Hangjun Zhan0
Lam Nguyen0
Shyr Jiann Li0
Edits on 30 Jul, 2023
Golden AI
Infobox
Patent Citations Received
Edits on 12 Jul, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 14 Jun, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 6 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
0
Current Assignee
0
Patent Jurisdiction
Patent Number
100937310
Date of Patent
October 9, 2018
0Patent Application Number
154674640
Date Filed
March 23, 2017
0Patent Citations Received
Patent Primary Examiner
Edits on 22 Mar, 2023
Golden AI
Infobox
Patent Citations Received
Edits on 22 Sep, 2022
Golden AI
Infobox
Patent Citations Received
Edits on 7 Sep, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 22 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10093731 Anti-IL31 antibodies for veterinary use
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10093731
Date of patent
October 9, 2018
Patent application number
15467464
Date Filed
March 23, 2017
Patent primary examiner
Find more entities like US Patent 10093731 Anti-IL31 antibodies for veterinary use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
